Oropharyngeal microbiota profi ling in chronic tonsillitis patients receiving polyvalent pyobacteriophage: A non-randomised experimental clinical trial

Background. Recent years have witnessed a 1.5–1.8-fold growth of chronic palatine tonsillitis. Choosing optimal treatment remains relevant in this illness despite ample research and improvement in therapy and diagnosis.

Objectives. An analysis of oropharyngeal microflora in chronic tonsillitis patients receiving a polyvalent pyobacteriophage treatment.

Methods. A total of 126 patients diagnosed with compensated chronic tonsillitis were followed up over 2018–2021. Qualitative and quantitative traits of oropharyngeal microflora have been assessed at baseline, immediately upon completion and past 3 months of treatment. The patients were separated between two cohorts: the main one (n = 65) had palatine tonsil lacunae irrigation with a Tonsillor MM unit and received polyvalent pyobacteriophage, while the comparison cohort (n = 61) only had palatine tonsil lacunae sanitation with Tonsillor MM. The trial included a control healthy volunteers cohort. Pearson’s chi-square method was used for statistical analyses with the SPSS 23 software. Statistical significance was obtained at p < 0.05.

Results. Quantitative comparisons of microbiotic strain persistence in tonsillar mucosa (isolation rate, microbial colonisation density) showed a significant prevalence of enterobacterial staphylococci and ß-haemolytic streptococci, Gram-negative anaerobic bacteria and fungi in chronic tonsillitis patients compared to the control cohort (p < 0.05). Therapy positively impacted microbiota vs. control, but the best effect was observed with polyvalent pyobacteriophage. Microbiological assays in dynamic patient follow-up demonstrated stability of the results attained. The Tonsillor MM sanitation cohort revealed a 2–3 degree dysbiosis in 47.5% (29) patients in 3 months, while the polyvalent pyobacteriophage cohort only had 7.7% (5) such patients (p <  0.01).

Conclusion. The trial demonstrates efficacy and relevance of pyobacteriophage treatment in chronic tonsillitis, primarily at the microenvironmental level.

1. Borisova O.Yu., Aleshkin V.A., Pimenova A.S., Krukov A.I., Kunelskaya N.L., Gurov A.V., Shadrin G.B., Tovmasyan A.S., Efimov B.A., Kafarskaya L.I. Microbial landscape of microflora of a pharynx at patients with tonsillit’s pathology. Russian Journal of Infection and Immunity. 2015; 5(3): 225–232 (In Russ., English abstract). DOI: 10.15789/2220-7619-2015-3-225-232

2. Tsyrkunov V.M., Rybak N.A., Vasilev A.V., Rybak R.F. Microbiological and morphological aspects of chronic tonsillitis. Infekcionnye Bolezni. 2016; 14(1): 42–47 (In Russ., English abstract). DOI: 10.20953/1729-9225-2016-1-42-47

3. Nacharov P., Ryazantsev S. Etiologic and pathogenetic diagnosis of chronic tonsillitis. Vrach. 2018; 29(3): 26–29 (In Russ., English abstract). DOI: 10.29296/25877305-2018-03-06

4. Choi D.H., Park J., Choi J.K., Lee K.E., Lee W.H., Yang J., Lee J.Y., Park Y.J., Oh C., Won H.R., Koo B.S., Chang J.W., Park Y.S. Association between the microbiomes of tonsil and saliva samples isolated from pediatric patients subjected to tonsillectomy for the treatment of tonsillar hyperplasia. Exp. Mol. Med. 2020; 52(9): 1564–1573. DOI: 10.1038/s12276-020-00487-6

5. Alasil S.M., Omar R., Ismail S., Yusof M.Y., Dhabaan G.N., Abdulla M.A. Evidence of Bacterial Biofilms among Infected and Hypertrophied Tonsils in Correlation with the Microbiology, Histopathology, and Clinical Symptoms of Tonsillar Diseases. Int. J. Otolaryngol. 2013; 2013: 408238. DOI: 10.1155/2013/408238

6. Vestby L.K., Grønseth T., Simm R., Nesse L.L. Bacterial Biofilm and its Role in the Pathogenesis of Disease. Antibiotics (Basel). 2020; 9(2): 59. DOI: 10.3390/antibiotics9020059

7. Abu Bakar M., McKimm J., Haque S.Z., Majumder M.A.A., Haque M. Chronic tonsillitis and biofilms: a brief overview of treatment modalities. J. Inflamm. Res. 2018; 11: 329–337. DOI: 10.2147/JIR.S162486.

8. Nesterova A.A., Vermienko V.V. The specific features of lacunar microbiome in the patients with chronic tonsillitis and gastroesophageal reflux disease. Russian Otorhinolaryngology. 2018; 92(1): 85–92 (In Russ., English abstract). DOI: 10.18692/1810-4800-2018-1-85-92

9. Cho S.W., Yang S.K. What Does the Microbiome in the Tonsil Tell Us? Clin. Exp. Otorhinolaryngol. 2021; 14(3): 247–248. DOI: 10.21053/ceo.2021.01074

10. Tansirichaiya S., Reynolds L.J., Roberts A.P. Functional Metagenomic Screening for Antimicrobial Resistance in the Oral Microbiome. Methods. Mol. Biol. 2021; 2327: 31–50. DOI: 10.1007/978-1-0716-1518-8_3

11. Iuchi H., Ohori J., Kiyama S., Imuta N., Nishi J., Kurono Y., Yamashita M. Effectiveness of antibacterial agents against cell-invading bacteria such as Streptococcus pyogenes and Haemophilus influenzae. BMC Microbiol. 2021; 21(1): 148. DOI: 10.1186/s12866-021-02217-y

12. Dumre S.P., Sapkota K., Adhikari N., Acharya D., Karki M., Bista S., Basanyat S.R., Joshi S.K. Asymptomatic throat carriage rate and antimicrobial resistance pattern of Streptococcus pyogenes in Nepalese school children. Kathmandu Univ. Med. J. (KUMJ). 2009; 7(28): 392-396. DOI: 10.3126/kumj.v7i4.2760

13. Brietzke S.E., Andreoli S.M. Systematic Review and Meta-analysis of the Change in Pharyngeal Bacterial Cultures After Pediatric Tonsillectomy. Otolaryngol. Head. Neck. Surg. 2021; 164(2): 264–270. DOI: 10.1177/0194599820944907

14. Fischetti V.A., Dale J.B. One More Disguise in the Stealth Behavior of Streptococcus pyogenes. mBio. 2016; 7(3): e00661-16. DOI: 10.1128/mBio.00661-16

15. Davies F.J., Olme C., Lynskey N.N., Turner C.E., Sriskandan S. Streptococcal superantigen-induced expansion of human tonsil T cells leads to altered T follicular helper cell phenotype, B cell death and reduced immunoglobulin release. Clin. Exp. Immunol. 2019; 197(1): 83–94. DOI: 10.1111/cei.13282

16. Fiedler T., Köller T., Kreikemeyer B. Streptococcus pyogenes biofilms-formation, biology, and clinical relevance. Front. Cell Infect. Microbiol. 2015; 5: 15. DOI: 10.3389/fcimb.2015.00015

17. Lavrenova G.V., Karpishchenko S.A., Shahnazarov A.E., Muratova E.I. The role of lymphatic drainage therapy in complex treatment of chronic tonsillitis. Folia Otorhinolaryngologiae et Pathologiae Respiratoriae. 2019; 25(1): 108–112 (In Russ., English abstract). DOI: 10.33848/foliorl23103825-2019-25-1-108-112